Irofulven is a natural toxin isolated from the fungus Omphalotus illudens. Irofulven is a DNA damaging agent and antineoplastic agent used to treat advanced solid tumors, including prostate cancer, ovarian cancer, and pancreatic cancer. Irofulven alkylates DNA and protein macromolecules to form adducts and keep cells in the S phase of the cell cycle. The agent needs to undergo NADPH-dependent metabolism through alkenal/an oxidoreductase to be active.

[1] Glatt H, Pietsch KE, Sturla SJ, Meinl W. Sulfotransferase-independent genotoxicity of illudin S and its acylfulvene derivatives in bacterial and mammalian cells. Arch Toxicol. 2014 Jan;88(1):161-9.

[2] Staake MD, Kashinatham A, McMorris TC, Estes LA, Kelner MJ. Hydroxyurea derivatives of irofulven with improved antitumor efficacy. Bioorg Med Chem Lett. 2016 Apr 1;26(7):1836-8.

[3] Tummala H, Kirwan M, Walne AJ, Hossain U, Jackson N, Pondarre C, Plagnol V, Vulliamy T, Dokal I. ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function. Am J Hum Genet. 2014 Feb 6;94(2):246-56.